SR

Saket Ranjan

Active Director Director DIN 03090080
DIN 03090080 First appointment Jun 2010 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2010
Shareholding value •••• Premium profile

About Saket Ranjan

Data last updated:

Saket Ranjan is a Director at Amox Pharmaceuticals Private Limited (since 2010). The company operates in Chemicals. Amox Pharmaceuticals Private Limited reported revenue of ₹67.7 Lakh (FY 2024).

DIN 03090080
Primary Designation Director
Industry Chemicals
First Appointment 15 Jun 2010
Oldest Company Age 16 yrs
Largest company Amox Pharmaceuticals Private Limited · ₹67.7 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Amox Pharmaceuticals Private Limited U51397BR2010PTC015756
Director15 Jun 20102010₹67.7 Lakh (FY 2024)Active

Board colleagues of Saket Ranjan

Directorship timeline

Open interactive timeline →
Amox Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Saket Ranjan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saket Ranjan

Saket Ranjan currently holds 1 directorship: Amox Pharmaceuticals Private Limited (Director, since 15 Jun 2010, revenue ₹67.7 Lakh (FY 2024)).

Saket Ranjan was first appointed on 15 Jun 2010 as Director at Amox Pharmaceuticals Private Limited.

The current boards of Saket Ranjan's companies include Manoj Ranjan (Amox Pharmaceuticals Private Limited), Rajeev Raj (Amox Pharmaceuticals Private Limited), Rakhi Singh (Amox Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available